288 related articles for article (PubMed ID: 12552344)
21. The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.
Koch CJ; Shuman AL; Jenkins WT; Kachur AV; Karp JS; Freifelder R; Dolbier WR; Evans SM
Int J Radiat Biol; 2009 Dec; 85(12):1137-47. PubMed ID: 19995239
[TBL] [Abstract][Full Text] [Related]
22. A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5).
Chitneni SK; Bida GT; Dewhirst MW; Zalutsky MR
Nucl Med Biol; 2012 Oct; 39(7):1012-8. PubMed ID: 22727821
[TBL] [Abstract][Full Text] [Related]
23. In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using (19)F magnetic resonance spectroscopy.
Hoff MN; Yapp DT; Yung AC; Oliver TS; Kozlowski P
Int J Radiat Biol; 2008 Mar; 84(3):237-42. PubMed ID: 18300024
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia is important in the biology and aggression of human glial brain tumors.
Evans SM; Judy KD; Dunphy I; Jenkins WT; Hwang WT; Nelson PT; Lustig RA; Jenkins K; Magarelli DP; Hahn SM; Collins RA; Grady MS; Koch CJ
Clin Cancer Res; 2004 Dec; 10(24):8177-84. PubMed ID: 15623592
[TBL] [Abstract][Full Text] [Related]
25. Repeatability of tumour hypoxia imaging using [
Silvoniemi A; Suilamo S; Laitinen T; Forsback S; Löyttyniemi E; Vaittinen S; Saunavaara V; Solin O; Grönroos TJ; Minn H
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):161-169. PubMed ID: 29075831
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia in human intraperitoneal and extremity sarcomas.
Evans SM; Hahn SM; Magarelli DP; Zhang PJ; Jenkins WT; Fraker DL; Hsi RA; McKenna WG; Koch CJ
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):587-96. PubMed ID: 11173159
[TBL] [Abstract][Full Text] [Related]
27. Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
Zanzonico P; O'Donoghue J; Chapman JD; Schneider R; Cai S; Larson S; Wen B; Chen Y; Finn R; Ruan S; Gerweck L; Humm J; Ling C
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):117-28. PubMed ID: 14523586
[TBL] [Abstract][Full Text] [Related]
28. Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
Evans SM; Hahn S; Pook DR; Jenkins WT; Chalian AA; Zhang P; Stevens C; Weber R; Weinstein G; Benjamin I; Mirza N; Morgan M; Rubin S; McKenna WG; Lord EM; Koch CJ
Cancer Res; 2000 Apr; 60(7):2018-24. PubMed ID: 10766193
[TBL] [Abstract][Full Text] [Related]
29. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
[TBL] [Abstract][Full Text] [Related]
30. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
Evans SM; Jenkins WT; Shapiro M; Koch CJ
Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.
Koch CJ; Evans SM
Adv Exp Med Biol; 2003; 510():285-92. PubMed ID: 12580442
[TBL] [Abstract][Full Text] [Related]
33. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts.
Lord EM; Harwell L; Koch CJ
Cancer Res; 1993 Dec; 53(23):5721-6. PubMed ID: 8242628
[TBL] [Abstract][Full Text] [Related]
34. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts.
Lee J; Siemann DW; Koch CJ; Lord EM
Int J Cancer; 1996 Jul; 67(3):372-8. PubMed ID: 8707411
[TBL] [Abstract][Full Text] [Related]
35. Imaging of tumor hypoxia to predict treatment sensitivity.
Minn H; Grönroos TJ; Komar G; Eskola O; Lehtiö K; Tuomela J; Seppänen M; Solin O
Curr Pharm Des; 2008; 14(28):2932-42. PubMed ID: 18991711
[TBL] [Abstract][Full Text] [Related]
36. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
37. Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.
Bansal A; Shuyan W; Hara T; Harris RA; Degrado TR
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1192-203. PubMed ID: 18264706
[TBL] [Abstract][Full Text] [Related]
38. Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis.
Mahy P; De Bast M; Gillart J; Labar D; Grégoire V
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):553-6. PubMed ID: 16523307
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia.
Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF
Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
